Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species

Area of Science:

• Microbiology
• Drug Discovery
• Molecular Biology

Background:

• Antibiotic resistance necessitates novel therapeutic strategies against bacterial infections.
• Anti-virulence approaches offer a promising alternative by targeting bacterial pathogenicity rather than viability, potentially reducing selective pressure for resistance.

Purpose of the Study:

• To identify and characterize a small molecule inhibitor of HlyU, a key virulence regulator in *Vibrio vulnificus*.
• To evaluate the anti-virulence efficacy of the identified molecule, CM14, in vitro and in vivo.

Main Methods:

• High-throughput screening to identify HlyU inhibitors.
• In vitro assays measuring bacterial growth, gene expression, hemolysis, and host cell lysis.
• In vivo studies assessing survival rates, organ damage, and inflammation in infected mice.
• Biochemical, mass spectrometric, and mutational analyses to determine the mechanism of action.

Main Results:

• CM14 was identified as a potent inhibitor of HlyU activity in *Vibrio vulnificus*.
• CM14 attenuated virulence gene expression, hemolysis, and host cell damage without impacting bacterial growth.
• CM14 treatment significantly improved survival rates in a mouse model by reducing organ damage and inflammation.
• Mechanism of action involves CM14 covalently modifying Cys30 of HlyU, preventing DNA binding.

Conclusions:

• CM14 represents a novel anti-virulence agent targeting HlyU.
• This molecule demonstrates broad potential against HlyU-dependent *Vibrio* species with a low risk of resistance development.